You are here

Article info

Article menu
Download PDFPDF
Letter
A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis

Authors

  1. B J F van den Bemt, Sint Maartenskliniek, department of Pharmacy, PO Box 9011, 6500 GM, Nijmegen, The Netherlands; b.vandenbemt{at}maartenskliniek.nl
View Full Text

Citation

van den Bemt BJF, Vos K, Broeder AAD, et al
A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis
Annals of the Rheumatic Diseases 2009;68:1368-1369.

Publication history

  • Accepted October 3, 2008
  • First published July 15, 2009.
Online issue publication 
March 09, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group and European League Against Rheumatism